IMRX vs. AVGX

Last updated Jun 4, 2026

IMRX (Immuneering Corporation) is a stock, while AVGX (Defiance Daily Target 2X Long AVGO ETF) is Leveraged Equities fund actively managed by Defiance. Over the past year, IMRX returned 132.14% vs 156.34% for AVGX. At a 0.17 correlation, their price movements are largely independent.

Performance

IMRX vs. AVGX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Immuneering Corporation (IMRX) and Defiance Daily Target 2X Long AVGO ETF (AVGX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, IMRX achieves a -30.85% return, which is significantly lower than AVGX's 69.89% return.

IMRX

• 1D: 6.31%
• 1M: -15.51%
• YTD: -30.85%
• 6M: -32.49%
• 1Y: 132.14%
• 3Y*: -19.59%
• 5Y*: —
• 10Y*: —

AVGX

• 1D: -0.83%
• 1M: 29.49%
• YTD: 69.89%
• 6M: 35.83%
• 1Y: 156.34%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

IMRX vs. AVGX - Yearly Performance Comparison

	2026 (YTD)	2025	2024
IMRX Immuneering Corporation	-30.85%	199.09%	109.52%
AVGX Defiance Daily Target 2X Long AVGO ETF	69.89%	46.98%	69.92%

Correlation

The correlation between IMRX and AVGX is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.16
Correlation (All Time) Calculated using the full available price history since Aug 23, 2024	0.17

Return for Risk

IMRX vs. AVGX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IMRX

IMRX Risk / Return Rank: 76
IMRX Sharpe Ratio Rank: 73
IMRX Sortino Ratio Rank: 77
IMRX Omega Ratio Rank: 81
IMRX Calmar Ratio Rank: 78
IMRX Martin Ratio Rank: 71

AVGX

AVGX Risk / Return Rank: 50
AVGX Sharpe Ratio Rank: 53
AVGX Sortino Ratio Rank: 50
AVGX Omega Ratio Rank: 48
AVGX Calmar Ratio Rank: 59
AVGX Martin Ratio Rank: 40

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IMRX vs. AVGX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Immuneering Corporation (IMRX) and Defiance Daily Target 2X Long AVGO ETF (AVGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	IMRX	AVGX	Difference
Sharpe ratio: Return per unit of total volatility	1.07	1.83	-0.76
Sortino ratio: Return per unit of downside risk	2.16	2.45	-0.29
Omega ratio: Gain probability vs. loss probability	1.31	1.31	+0.01
Calmar ratio: Return relative to maximum drawdown	2.40	2.91	-0.51
Martin ratio: Return relative to average drawdown	3.98	6.49	-2.51
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

IMRX vs. AVGX - Sharpe Ratio Comparison

The current IMRX Sharpe Ratio is 1.07, which is lower than the AVGX Sharpe Ratio of 1.83. The chart below compares the historical Sharpe Ratios of IMRX and AVGX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	IMRX	AVGX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.07	1.83	-0.76
Sharpe Ratio (All Time) Calculated using the full available price history	-0.21	1.21	-1.43

Drawdowns

IMRX vs. AVGX - Drawdown Comparison

The maximum IMRX drawdown since its inception was -96.86%, which is greater than AVGX's maximum drawdown of -70.97%. Use the drawdown chart below to compare losses from any high point for IMRX and AVGX.

Drawdown Indicators

	IMRX	AVGX	Difference
Max Drawdown Largest peak-to-trough decline	-96.86%	-70.97%	-25.89%
Max Drawdown (1Y) Largest decline over 1 year	-55.35%	-54.09%	-1.26%
Max Drawdown (3Y) Largest decline over 3 years	-90.98%	—	—
Current Drawdown Current decline from peak	-86.14%	-0.83%	-85.31%
Average Drawdown Average peak-to-trough decline	-77.60%	-22.71%	-54.89%
Ulcer Index Depth and duration of drawdowns from previous peaks	33.32%	24.20%	+9.12%

Volatility

IMRX vs. AVGX - Volatility Comparison

Immuneering Corporation (IMRX) has a higher volatility of 32.23% compared to Defiance Daily Target 2X Long AVGO ETF (AVGX) at 23.50%. This indicates that IMRX's price experiences larger fluctuations and is considered to be riskier than AVGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	IMRX	AVGX	Difference
Volatility (1M) Calculated over the trailing 1-month period	32.23%	23.50%	+8.73%
Volatility (6M) Calculated over the trailing 6-month period	78.61%	61.90%	+16.71%
Volatility (1Y) Calculated over the trailing 1-year period	123.87%	85.97%	+37.90%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	114.62%	104.65%	+9.97%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	114.62%	104.65%	+9.97%

Dividends

IMRX vs. AVGX - Dividend Comparison

IMRX has not paid dividends to shareholders, while AVGX's dividend yield for the trailing twelve months is around 0.97%.

Position	TTM	2025	2024
AVGX Defiance Daily Target 2X Long AVGO ETF	0.97%	1.65%	0.81%
IMRX Immuneering Corporation	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both IMRX and AVGX in my portfolio?

IMRX and AVGX have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, IMRX or AVGX?

IMRX has higher volatility (32.23%) compared to AVGX (23.50%). In terms of maximum drawdown, IMRX dropped -96.86% vs AVGX's -70.97%.

Which has better risk-adjusted returns?

AVGX currently has the higher Sharpe Ratio (1.83 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.